Antique Research Initiates Coverage on Indian Hospital Stocks with Up to 37% Upside
India’s organised hospital sector is on the cusp of a significant growth phase driven by expanding healthcare demand, higher insurance penetration, and capacity augmentation. Antique, a leading brokerage firm, recently initiated coverage on four prominent hospital stocks—Apollo Hospitals Enterprise, Medanta (Global Health Ltd.), Healthcare Global Enterprises (HCG), and Max Healthcare Institute—highlighting their potential for robust earnings growth and significant upside.
Strong Long-Term Growth in India’s Hospital Sector
According to Antique, India’s healthcare delivery market is expected to grow at a compound annual growth rate (CAGR) of 10-12%, reaching Rs 12 lakh crore by FY25-FY30. The private healthcare providers are projected to increase their share of treatment services from 64% in FY20 to 69% by FY30.
The brokerage emphasizes that the sector’s growth is driven by rising patient demand, increasing insurance penetration, medical tourism boost, and regulatory support. Additionally, capacity additions, especially through brownfield expansion projects, are set to accelerate growth while offering faster ramp-up and higher returns on capital.
Coverage Initiated on Leading Hospital Stocks
Antique assigned ‘Buy’ ratings to Apollo Hospitals, Medanta, Healthcare Global Enterprises, and Artemis Medicare Services, while giving a ‘Hold’ rating to Max Healthcare due to valuation concerns despite a strong operational outlook.
Apollo Hospitals Enterprise Ltd. – Buy
Apollo is one of India’s largest healthcare providers with 8,131 beds across its network. Antique projects a target price of Rs 9,790, implying an upside of approximately 14%. The company is expected to add around 1,000 beds from FY26 to FY28 through brownfield expansions and acquisitions.
Revenue, EBITDA, and PAT are forecasted to grow at CAGRs of 16%, 20%, and 24% respectively over FY26-28. Occupancy rates are anticipated to improve to over 68%, supported by a 6% CAGR increase in average revenue per patient.
Medanta (Global Health Ltd.) – Buy
Medanta operates six hospitals with 3,665 beds and plans to add approximately 490 beds through brownfield expansion in FY27. Antique’s target price stands at Rs 1,520, suggesting a 15% upside.
The brokerage expects Medanta’s revenue, EBITDA, and PAT to grow at 18%, 25%, and 22% CAGR respectively over FY26-28. EBITDA margins are forecasted to expand by 290 basis points, while EBITDA per bed is projected to rise 16% annually.
Healthcare Global Enterprises Ltd. (HCG) – Buy
As India’s only listed pure-play oncology hospital network, HCG operates more than 2,600 beds across 25 centers in 19 cities. Antique highlights a 1,000-bed expansion pipeline by FY30, with a mix of 600 brownfield and 400 greenfield beds.
With a target price of Rs 840, Antique anticipates up to 37% upside for HCG. Revenue, EBITDA, and PAT are expected to grow at 16%, 25%, and an impressive 116% CAGR respectively over FY26-28, supported by improved utilization, payor mix, and operational improvements under KKR’s ownership.
Max Healthcare Institute Ltd. – Hold
Max Healthcare currently operates 6,100 beds across 21 facilities and plans to increase capacity by 66% to about 10,200 beds by FY30, predominantly through brownfield projects and asset-light models.
Despite strong growth projections with revenue, EBITDA, and PAT growing at 19%, 21%, and 19% CAGRs over FY26-28, Antique maintains a ‘Hold’ rating due to the stock’s already strong performance and valuation concerns.
Artemis Medicare Services – Buy
Artemis plans to triple its bed capacity from 700 to around 2,200 in the next 3-4 years by adding beds primarily in Gurugram, Raipur, and South Delhi. Antique assigns a ‘Buy’ rating with a target price of Rs 340, representing a 29% upside.
Revenue, EBITDA, and PAT are projected to grow at a CAGR of 27%, 34%, and 36% over FY26-28 with an expected margin expansion due to improved operating leverage.
Positive Sector Outlook Supported by Policy and Demand Factors
Antique views concerns around hospital overcapacity as overstated, citing strong demand drivers including rising insurance penetration, government schemes like Ayushman Bharat and PM-JAY, an increasing burden of chronic diseases, and growing medical tourism.
The brokerage also notes recent regulatory developments, such as revised building norms and Competition Commission of India’s integrated healthcare delivery model guidelines, as positive for sector growth. These factors together underpin a bullish sector outlook.
Conclusion
The organised hospital sector in India is set for multi-year growth backed by significant capacity expansions, improving occupancy rates, favourable case mix, and healthy financial positions of leading players. Antique recommends investors consider ‘Buy’ positions in Apollo Hospitals, Medanta, Healthcare Global Enterprises, and Artemis Medicare Services, while taking a cautious ‘Hold’ stance on Max Healthcare due to its valuation despite robust fundamentals.
Disclaimer: The information and equity research ratings provided are for educational purposes only and do not constitute financial advice. Investors should conduct independent research and consult a SEBI-registered advisor before making investment decisions.
